SynthesisCancer medicine2024
Cancer risks related to intellectual disabilities: A systematic review.
Synthesis in Cancer medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 3 syntheses or guidelines pooled it, 22 citations in OpenAlex.
- Cancer prevention and screening for people with intellectual disabilities in Europe: a systematic review and recommendations for policy and practice.Frontiers in public health · 2026Pooled it
- Cancer in adults with intellectual disability: a systematic review of prevalence and incidence.BMC cancer · 2025Pooled it
- Cancer risks related to intellectual disabilities: A systematic review.Cancer medicine · 2024Pooled it
- Genetic Syndromes Including Intellectual Disability and Different Cancer Types.Molecular syndromology · 2026Review
- Bowel cancer care in individuals with an intellectual disability: a population-based cohort study of symptoms, diagnostic pathways, treatment and survival.BMC medicine · 2026Article
- Cancer Incidence in People With Intellectual Disability and Down Syndrome in Australia: A Cohort Study.Cancer medicine · 2026Article
- Preventive breast health care, an embarrassing subject for women with intellectual disability.Journal of intellectual disabilities : JOID · 2026Article
- Age-Specific Diagnostic Panorama Among People With Intellectual Disabilities in Comparison With the General Population: A Longitudinal Register Study (IDcare).Journal of intellectual disability research : JIDR · 2026Article
- Exploring Inclusion in Austria's Breast Cancer Screening:A Dual-Perspective Study of Women with Intellectual Disabilities and Their Caregivers.International journal of environmental research and public health · 2026Article
- Colorectal Cancer Screening Among People With Intellectual Disabilities.JAMA network open · 2026Article
- Adaptation and validation of the cancer awareness measure tool for individuals with intellectual disabilities in Hungary.Frontiers in public health · 2026Article
- Cancer diagnoses, referrals, and survival in people with a learning disability in the UK: a population-based, matched cohort study.The Lancet regional health. Europe · 2026Article
- Article
- Cancer prevalence and care disparities among individuals with intellectual disabilities: a cross-sectional pan-cancer analysis.ESMO real world data and digital oncology · 2025Article
- Cancer incidence and diagnostic characteristics in people with intellectual disabilities in the Netherlands: a national registry-based cohort study.BMJ oncology · 2025Article
- Cancer in people with intellectual disability: lower incidence, later-stage diagnosis - who counts? who cares?BMJ oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
Abstract
backgroundPeople with intellectual disabilities (ID) face barriers in cancer care contributing to poorer oncological outcomes. Yet, understanding cancer risks in the ID population remains incomplete.
aimTo provide an overview of cancer incidence and cancer risk assessments in the entire ID population as well as within ID-related disorders.
methodsThis systematic review examined cancer risk in the entire ID population and ID-related disorders. We systematically searched PubMed (MEDLINE) and EMBASE for literature from January 1, 2000 to July 15, 2022 using a search strategy combining terms related to cancer, incidence, and ID.
resultsWe found 55 articles assessing cancer risks in the ID population at large groups or in subgroups with ID-related syndromes, indicating that overall cancer risk in the ID population is lower or comparable with that of the general population, while specific disorders (e.g., Down's syndrome) and certain genetic mutations may elevate the risk for particular cancers. DISCUSSION: The heterogeneity within the ID population challenges precise cancer risk assessment at the population level. Nonetheless, within certain subgroups, such as individuals with specific ID-related disorders or certain genetic mutations, a more distinct pattern of varying cancer risks compared to the general population becomes apparent.
conclusionMore awareness, and personalized approach in cancer screening within the ID population is necessary.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.